We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

4 hedge funds and large institutions have $57.6K invested in Amedisys in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 315 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 319 → 4 (-315)

99.1% less ownership

Funds ownership: 99.1% → 0% (-99%)

99% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 315

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $3.2B → $57.6K (-$3.2B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-315
Holders Change %
-98.75%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
315
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
IA
IFP Advisors
Florida
+$7.08K
2
MCI
MRP Capital Investments
Georgia
+$2.46K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$329M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$299M
3
PCM
Pentwater Capital Management
Florida
-$169M
4
Fidelity International
Fidelity International
Bermuda
-$129M
5
AAM
Alpine Associates Management
Florida
-$108M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
– -$44.7M -454,519 Closed
Millennium Management
27
Millennium Management
New York
– -$43.5M -441,684 Closed
Calamos Advisors
28
Calamos Advisors
Illinois
– -$40.3M -409,603 Closed
Renaissance Technologies
29
Renaissance Technologies
New York
– -$35.8M -364,098 Closed
Charles Schwab
30
Charles Schwab
California
– -$34.4M -349,483 Closed
GAM
31
Gotham Asset Management
New York
– -$33.7M -342,392 Closed
HCM
32
Highbridge Capital Management
New York
– -$33.3M -338,364 Closed
SGCM
33
Sand Grove Capital Management
United Kingdom
– -$30.3M -308,254 Closed
Northern Trust
34
Northern Trust
Illinois
– -$28.6M -290,933 Closed
Neuberger Berman Group
35
Neuberger Berman Group
New York
– -$26.6M -270,324 Closed
LP
36
LMR Partners
United Kingdom
– -$25.5M -259,402 Closed
Goldman Sachs
37
Goldman Sachs
New York
– -$23.9M -242,944 Closed
Bank of New York Mellon
38
Bank of New York Mellon
New York
– -$22.3M -226,518 Closed
GCIA
39
Gabelli & Co Investment Advisers
New York
– -$22.1M -224,443 Closed
GF
40
Gabelli Funds
New York
– -$19.9M -201,903 Closed
Hudson Bay Capital Management
41
Hudson Bay Capital Management
Connecticut
– -$19.4M -197,126 Closed
Citigroup
42
Citigroup
New York
– -$18.7M -189,966 Closed
Morgan Stanley
43
Morgan Stanley
New York
– -$18.5M -188,387 Closed
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
– -$18.5M -187,627 Closed
Marshall Wace
45
Marshall Wace
United Kingdom
– -$18.3M -186,111 Closed
OBAM
46
ODDO BHF Asset Management
France
– -$17.1M -174,277 Closed
QCM
47
Quantinno Capital Management
New York
– -$16.2M -164,330 Closed
UBS AM
48
UBS AM
Illinois
– -$15.5M -157,516 Closed
Amundi
49
Amundi
France
– -$15.1M -157,445 Closed
WCMNY
50
Westchester Capital Management (New York)
New York
– -$15.2M -154,583 Closed
1
2
3 4 5

AMED Hedge Fund Activity: Q3 2025 in Review

4 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2025, worth a combined $57.6K — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 315 funds closed out of AMED and 2 opened new positions — a net loss of 313 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $7.08K. The largest seller was BlackRock, exiting entirely with an estimated $329M sold.

  • 4 institutional investors held Amedisys (AMED) as of Q3 2025, down from 319 in Q2 2025.
  • Funds reported $57.6K of Amedisys stock for Q3 2025, down 100% quarter-over-quarter.
  • 2 funds opened new Amedisys positions in Q3 2025 and 315 closed out, a net change of -313 holders.
  • The largest Amedisys buyer in Q3 2025 was IFP Advisors, an estimated $7.08K added.
  • The largest Amedisys seller in Q3 2025 was BlackRock, an estimated $329M sold.

Based on aggregated 13F filings for Q3 2025.